Logo

Shelf Life

Proper storage of biologic medications is critical for maintaining drug efficacy and patient safety. Temperature excursions—even brief exposures to room temperature—can compromise medication stability and therapeutic effectiveness. This reference tool provides quick access to room temperature allowances and latex allergy information for biologic medications.

How to Use:

Use the medication filter to quickly locate specific products by brand name or active ingredient. Each entry displays two critical pieces of information:

  • Room Temperature Allowance: The maximum time medication can remain at room temperature (typically 68-77°F or 20-25°C) without compromising stability. This is critical when patients travel, during shipping, or if refrigeration is temporarily unavailable.
  • Latex in Needle/Vial Cover: Indicates whether needle shields, vial stoppers, or syringe components contain natural rubber latex. Essential for patients with latex allergies or sensitivities.

All information is verified against current FDA-approved prescribing information. Different formulations of the same medication (pens vs prefilled syringes vs vials) may have different storage requirements— these variations are noted when applicable.

Abrilada™ (adalimumab-afzb)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Adbry® (tralokinumab-ldrm)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Amjevita® (adalimumab-atto)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Avsola® (infliximab-axxq)
Room Temp Allowance: Up to 6 months.
Latex in Needle/Vial: No
Bimzelx® (bimekizumab-bkzx)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Cimzia® (certolizumab pegol)
Room Temp Allowance: Up to 7 days.
Latex in Needle/Vial: Yes
Cosentyx® (secukinumab)
Room Temp Allowance: Up to 4 days or Sensoready pen and prefilled syringes. Use immediately for Unoready pen.
Latex in Needle/Vial: Yes: • Cosentyx 150 mg/mL Sensoready pen • Cosentyx 150 mg/mL prefilled syringe • Cosentyx 75 mg/0.5 mL prefilled syringe No: • UnoReady pen
Cyltezo® (adalimumab-adbm)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: Yes
Dupixent® (dupilumab)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Ebglyss® (lebrikizumab)
Room Temp Allowance: Up to 7 days.
Latex in Needle/Vial: No
Enbrel® (etanercept)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: Yes
Hadlima (adalimumab-bwwd)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Hulio® (adalimumab-fkjp)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Humira® (adalimumab)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: Yes: • Non-citrate-free (non-CF) versions No: • Citrate-free (CF) versions
Hyrimoz® (adalimumab-adaz)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: Yes
Idacio® (adalimumab-aacf )
Room Temp Allowance: Up to 28 days.
Latex in Needle/Vial: No
Ilumya® (tildrakizumab-asmn)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Imuldosa (ustekinumab-srlf)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Inflectra® (infliximab-dyyb)
Room Temp Allowance: Must be used immediately after removal from the refrigerator.
Latex in Needle/Vial: No
Nemluvio® (nemolizumab)
Room Temp Allowance: Before reconstution: 90 days. After reconstitution: 4 hours.
Latex in Needle/Vial: No
Otulfi (ustekinumab-aauz)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Pyzchiva® (ustekinumab-ttwe)
Room Temp Allowance: Up to 60 days.
Latex in Needle/Vial: No
Remicade® (infliximab)
Room Temp Allowance: Must be used immediately after removal from the refrigerator.
Latex in Needle/Vial: No
Renflexis® (infliximab-abda)
Room Temp Allowance: Must be used immediately after removal from the refrigerator.
Latex in Needle/Vial: No
Selarsdi™ (ustekinumab-aekn)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Siliq® (brodalumab)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Simlandi® (adalimumab-ryvk)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Skyrizi® (risankizumab-rzaa)
Room Temp Allowance: Brief room temperature exposure permitted, refrigerate until ready to use.
Latex in Needle/Vial: No
Spevigo® (spesolimab-sbzo)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Starjemza™ (ustekinumab-hmny)
Room Temp Allowance: Prefilled syringes: Up to 30 days. Vials: Up to 8 hours.
Latex in Needle/Vial: Yes (prefilled syringes only)
Stelara® (ustekinumab)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: Yes
Steqeyma (ustekinumab-stba)
Room Temp Allowance: Up to 15 days.
Latex in Needle/Vial: No
Taltz® (ixekizumab)
Room Temp Allowance: Up to 5 days.
Latex in Needle/Vial: No
Tremfya® (guselkumab)
Room Temp Allowance: Up to 4 hours.
Latex in Needle/Vial: No
Wezlana™ (ustekinumab-auub)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Xolair® (omalizumab)
Room Temp Allowance: Up to 2 days.
Latex in Needle/Vial: No
Yesintek™ (ustekinumab-kfce)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Yuflyma (adalimumab-aaty)
Room Temp Allowance: Up to 30 days.
Latex in Needle/Vial: No
Yusimry (adalimumab-aqvh)
Room Temp Allowance: Up to 14 days.
Latex in Needle/Vial: No
Understanding Room Temperature Storage

Room temperature allowances represent the maximum cumulative time a medication can safely remain outside refrigeration while maintaining stability and potency. These allowances are determined through rigorous stability testing by pharmaceutical manufacturers and approved by the FDA.

Key considerations:

  • Time is cumulative—if medication has been out of refrigeration multiple times, total time counts
  • Once room temperature allowance is exceeded, medication should be discarded
  • Medication cannot be "reset" by returning to refrigeration after time limit is reached
  • Temperature ranges vary—always verify specific requirements in prescribing information
  • Some medications require immediate use after removal from refrigeration (e.g., infliximab products)

Document temperature excursions and maintain records for quality assurance and regulatory compliance.

Latex Allergy Considerations

Natural rubber latex can cause allergic reactions ranging from mild skin irritation to severe anaphylaxis in sensitized individuals. Healthcare providers must be aware of latex content in medication delivery systems to prevent adverse reactions.

Where latex may be found:

  • Needle shields on prefilled syringes
  • Rubber stoppers on medication vials
  • Components of autoinjector pens
  • Packaging materials (less common)

Clinical implications:

  • Screen patients for latex allergies before prescribing biologics
  • Note that different formulations of the same drug may vary in latex content (e.g., Humira CF vs non-CF)
  • For latex-allergic patients, select latex-free alternatives when available
  • Healthcare providers with latex allergies should use appropriate precautions when handling products
Storage Best Practices

Proper storage protocols help maintain medication integrity and ensure patient safety:

  • Refrigeration: Store at 36-46°F (2-8°C) unless otherwise specified
  • Avoid freezing: Never freeze biologic medications; frozen product must be discarded
  • Protect from light: Keep medications in original packaging until use
  • Monitor temperatures: Use calibrated thermometers and document daily readings
  • Patient counseling: Educate patients on home storage requirements and travel considerations
  • Shipping protocols: Use validated cold chain shipping with temperature monitoring
  • Emergency procedures: Have protocols for refrigeration failures and power outages

When in doubt about storage integrity, contact the manufacturer or specialty pharmacy for guidance.

Formulation-Specific Differences

Different delivery systems for the same medication may have distinct storage requirements:

  • Prefilled Syringes vs Autoinjector Pens: Often have identical storage requirements but may differ in latex content (e.g., Cosentyx Sensoready vs UnoReady)
  • Vials vs Prefilled Systems: Vials may require immediate use after preparation (e.g., Starjemza vials vs prefilled syringes)
  • Reconstituted Products: Medications requiring reconstitution (e.g., Nemluvio) have very limited stability after preparation—typically hours, not days
  • Citrate-Free Formulations: May have different latex content than original formulations (e.g., Humira CF vs non-CF)

Always verify storage requirements for the specific formulation being dispensed or administered.

Disclaimer

While all storage data is carefully verified against official manufacturer prescribing information, ACDOSA assumes no liability for any errors, omissions, or clinical outcomes. This tool is for reference purposes only. Always consult current prescribing information for complete storage requirements and contact manufacturers for specific storage questions.

An unhandled error has occurred. Reload 🗙